Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile

Selectively targeting bacteria by tuning the molecular design of membrane-active peptidomimetic amphiphiles

(2018) Mohini M. Konai et al.   CHEMICAL COMMUNICATIONS

Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity

(2017) Shuimu Lin et al.   JOURNAL OF MEDICINAL CHEMISTRY

An Independent Evaluation of a Novel Peptide Mimetic, Brilacidin (PMX30063), for Ocular Anti-Infective

(2016) Regis P. Kowalski et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Clostridium difficile: from obscurity to superbug

(2016) J.S. Brazier   BRITISH JOURNAL OF BIOMEDICAL SCIENCE

A new antibiotic kills pathogens without detectable resistance

(2015) Losee L. Ling et al.   NATURE

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daily Bathing with Chlorhexidine and Its Effects on Nosocomial Infection Rates in Pediatric Oncology Patients

(2015) Chittalsinh M. Raulji et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance

(2015) Priscilla Johanesen et al.   Genes

Norspermidine Is Not a Self-Produced Trigger for Biofilm Disassembly

(2014) Laura Hobley et al.   CELL

Biofilm-Eradicating Properties of Quaternary Ammonium Amphiphiles: Simple Mimics of Antimicrobial Peptides

(2014) Megan C. Jennings et al.   CHEMBIOCHEM

Progress in the Discovery of Treatments for C. difficile Infection: A Clinical and Medicinal Chemistry Review

(2014) Lissa Tsutsumi et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Amino Acid Modified Xanthone Derivatives: Novel, Highly Promising Membrane-Active Antimicrobials for Multidrug-Resistant Gram-Positive Bacterial Infections

(2014) Jun-Jie Koh et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and Activity of Biomimetic Biofilm Disruptors

(2013) Thomas Böttcher et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Future novel therapeutic agents forClostridium difficileinfection

(2010) Hoonmo L Koo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine

(2009) M. Grare et al.   CLINICAL MICROBIOLOGY AND INFECTION

In Vitro Activity of Tomopenem (CS-023/RO4908463) against Anaerobic Bacteria

(2008) K. Tanaka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Update on the changing epidemiology of Clostridium difficile-associated disease

(2008) Lynne V McFarland   Nature clinical practice. Gastroenterology & hepatology